| |
| |
|
| Insider
Information: |
Gage L Patrick |
| Relationship: |
Director |
| City: |
Fremont |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
123,884 |
|
|
Indirect Shares
|
1,850 |
|
|
| Direct
Value |
$2,016,181 |
|
|
|
Indirect Value
|
$113,442 |
|
|
| Total
Shares |
125,734 |
|
|
| Total
Value |
$2,129,623 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
5.0
|
| Percentage
Gain/Loss : |
0.0%
|
 184.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PDL Biopharma Inc |
PDLI |
Interim CEO, Director |
2008-04-28 |
19,555 |
2004-05-24 |
0 |
Premium* |
|
|
Neose Technologies Inc |
NTEC |
Director |
2009-01-27 |
75,397 |
2005-05-05 |
0 |
Premium* |
|
|
Cytokinetics Inc |
CYTK |
Director |
2021-11-08 |
28,932 |
2021-11-08 |
1,850 |
Premium* |
|
|
Tetraphase Pharmaceuticals Inc |
TTPH |
Director |
2020-07-28 |
0 |
2020-07-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2021-11-08 |
4 |
S |
$41.33 |
$1,094,023 |
D/D |
(26,468) |
28,932 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2021-11-08 |
4 |
OE |
$4.02 |
$112,400 |
D/D |
26,468 |
33,098 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2021-10-01 |
4 |
A |
$36.74 |
$18,737 |
D/D |
510 |
28,932 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2021-07-01 |
4 |
A |
$20.98 |
$18,735 |
D/D |
893 |
28,422 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2021-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
27,529 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2021-03-19 |
4 |
OE |
$5.88 |
$58,800 |
D/D |
10,000 |
31,762 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2021-03-19 |
4 |
S |
$24.45 |
$244,468 |
D/D |
(10,000) |
21,762 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2021-03-12 |
4 |
S |
$21.22 |
$219,372 |
D/D |
(10,339) |
21,762 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2021-03-12 |
4 |
OE |
$5.88 |
$69,992 |
D/D |
10,339 |
25,095 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2021-01-04 |
4 |
A |
$19.56 |
$18,738 |
D/D |
958 |
21,762 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2020-12-15 |
4 |
S |
$21.00 |
$162,038 |
D/D |
(7,716) |
20,804 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2020-12-15 |
4 |
OE |
$12.96 |
$99,999 |
D/D |
7,716 |
28,520 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
Director |
– • – |
2020-07-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,944) |
0 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
Director |
– • – |
2020-07-28 |
4 |
D |
$0.00 |
$0 |
I/I |
(191) |
0 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2020-05-18 |
4 |
D |
$22.22 |
$56,194 |
D/D |
(2,529) |
20,804 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2020-05-18 |
4 |
OE |
$16.86 |
$56,194 |
D/D |
3,333 |
23,333 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2020-03-06 |
4 |
S |
$14.82 |
$118,592 |
D/D |
(8,000) |
20,000 |
0 |
% |
|
| TTPH |
Tetraphase Pharmaceutical... |
Director |
– • – |
2017-11-29 |
4 |
B |
$6.45 |
$25,026 |
D/D |
3,880 |
38,880 |
2.39 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2017-10-02 |
4 |
AS |
$14.40 |
$72,944 |
D/D |
(5,000) |
30,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2017-10-02 |
4 |
OE |
$4.02 |
$20,100 |
D/D |
5,000 |
35,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2017-09-01 |
4 |
AS |
$14.60 |
$73,623 |
D/D |
(5,000) |
30,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2017-09-01 |
4 |
OE |
$4.02 |
$20,100 |
D/D |
5,000 |
35,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2017-08-29 |
4 |
AS |
$14.00 |
$70,000 |
D/D |
(5,000) |
30,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2017-08-29 |
4 |
OE |
$4.02 |
$20,100 |
D/D |
5,000 |
35,000 |
0 |
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
Director |
– • – |
2017-03-15 |
4 |
B |
$7.47 |
$7,470 |
I/I |
1,000 |
3,825 |
2.1 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
